Revolution Medicines, Inc. Common Stock
Follow $RVMD
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $RVMD by emailVeridion Score
BETALOW CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is RVMD moving today?
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
RVMD overview
Related filings and maps
Congress activity in RVMD
No receipt-qualified Congressional disclosure is present for RVMD in the cached public ledger.
RVMD contract awards, year to date.
Public federal awards linked to this ticker.
RVMD lobbying filings, year to date.
Registered lobbying filings matched to Revolution Medicines, Inc. Common Stock.